225 related articles for article (PubMed ID: 24990091)
1. Efficacy and safety of losartan 100 mg/hydrochlorothiazide 12.5 mg in Japanese subjects with essential hypertension: two randomized, controlled trials.
Rakugi H; Tsuchihashi T; Shimada K; Numaguchi H; Nishida C; Yamaguchi H; Fujimoto G; Azuma K; Shirakawa M; Hanson ME; Fujita KP
Hypertens Res; 2014 Dec; 37(12):1042-9. PubMed ID: 24990091
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, randomized, double-blind, placebo-controlled, 8-week trial of the efficacy and tolerability of once-daily losartan 100 mg/hydrochlorothiazide 25 mg and losartan 50 mg/hydrochlorothiazide 12.5 mg in the treatment of moderate-to-severe essential hypertension.
Gradman AH; Brady WE; Gazdick LP; Lyle P; Zeldin RK
Clin Ther; 2002 Jul; 24(7):1049-61. PubMed ID: 12182251
[TBL] [Abstract][Full Text] [Related]
3. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
Lacourcière Y; Neutel JM; Schumacher H
Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
[TBL] [Abstract][Full Text] [Related]
4. A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension.
Gleim GW; Rubino J; Zhang H; Shahinfar S; Soffer BA; Lyle PA; Littlejohn TW; Feig PU
Clin Ther; 2006 Oct; 28(10):1639-48. PubMed ID: 17157119
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of fixed-dose losartan/hydrochlorothiazide/amlodipine combination versus losartan/hydrochlorothiazide combination in Japanese patients with essential hypertension.
Rakugi H; Tsuchihashi T; Shimada K; Numaguchi H; Nishida C; Yamaguchi H; Shirakawa M; Azuma K; Fujita KP
Clin Exp Hypertens; 2015; 37(3):260-6. PubMed ID: 25271811
[TBL] [Abstract][Full Text] [Related]
6. Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension. Losartan Trial Investigators.
Manolis AJ; Grossman E; Jelakovic B; Jacovides A; Bernhardi DC; Cabrera WJ; Watanabe LA; Barragan J; Matadamas N; Mendiola A; Woo KS; Zhu JR; Mejia AD; Bunt T; Dumortier T; Smith RD
Clin Ther; 2000 Oct; 22(10):1186-203. PubMed ID: 11110230
[TBL] [Abstract][Full Text] [Related]
7. Effect on blood pressure control of switching from valsartan monotherapy to losartan/hydrochlorothiazide in Asian patients with hypertension: results of a multicentre open-label trial.
Watanabe LA; Wei M; Sun N; Kim D; Chiang CE; Ke Y; Tseng CD; Coloma R; Vala M; Massaad R; Feig P; Guptha S
Curr Med Res Opin; 2006 Oct; 22(10):1955-64. PubMed ID: 17022855
[TBL] [Abstract][Full Text] [Related]
8. Telmisartan/Hydrochlorothiazide in comparison with losartan/hydrochlorothiazide in managing patients with mild-to-moderate hypertension.
Neutel JM; Littlejohn TW; Chrysant SG; Singh A;
Hypertens Res; 2005 Jul; 28(7):555-63. PubMed ID: 16335883
[TBL] [Abstract][Full Text] [Related]
9. Add-on effect of hydrochlorothiazide 12.5 mg in Japanese subjects with essential hypertension uncontrolled with losartan 50 mg and amlodipine 5 mg.
Rakugi H; Tsuchihashi T; Shimada K; Numaguchi H; Nishida C; Yamaguchi H; Shirakawa M; Azuma K; Fujita KP
Hypertens Res; 2015 May; 38(5):329-35. PubMed ID: 25716649
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive efficacy and safety of losartan alone and in combination with hydrochlorothiazide in adult African Americans with mild to moderate hypertension.
Flack JM; Saunders E; Gradman A; Kraus WE; Lester FM; Pratt JH; Alderman M; Green S; Vargas R; Espenshade M; Ceesay P; Alexander J; Goldberg A;
Clin Ther; 2001 Aug; 23(8):1193-208. PubMed ID: 11558858
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of amlodipine camsylate/losartan 5/100-mg versus losartan/hydrochlorothiazide 100/12.5-mg fixed-dose combination in hypertensive patients nonresponsive to losartan 100-mg monotherapy.
Suh SY; Ahn T; Bae JH; Lim DS; Lee SU; Kim YK; Hyon MS; Kim WH; Han KR; Park HK
Clin Ther; 2014 Oct; 36(10):1402-11. PubMed ID: 25146365
[TBL] [Abstract][Full Text] [Related]
12. Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension.
Oparil S; Barr E; Elkins M; Liss C; Vrecenak A; Edelman J
Clin Ther; 1996; 18(4):608-25. PubMed ID: 8879890
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of open-label losartan/hydrochlorothiazide combination therapy in Asian patients with hypertension not controlled with ACE inhibitor or ARB monotherapy.
Kim KS; Fan WH; Kim YD; Zhu W; Ngau YY; Tong P; Kim BS; Santos M; Lin WH; Buranakitjaroen P; Massaad R; Smith RD;
Hypertens Res; 2009 Jun; 32(6):520-6. PubMed ID: 19390542
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of losartan versus enalapril alone or in combination with hydrochlorothiazide in patients with essential hypertension.
Townsend R; Haggert B; Liss C; Edelman JM
Clin Ther; 1995; 17(5):911-23. PubMed ID: 8595643
[TBL] [Abstract][Full Text] [Related]
15. Controlled trial of losartan given concomitantly with different doses of hydrochlorothiazide in hypertensive patients.
Ruilope LM; Simpson RL; Toh J; Arcuri KE; Goldberg AI; Sweet CS
Blood Press; 1996 Jan; 5(1):32-40. PubMed ID: 8777471
[TBL] [Abstract][Full Text] [Related]
16. Long-term, open-label evaluation of the safety and efficacy of telmisartan 80 mg/hydrochlorothiazide 25 mg fixed-dose combination alone or with other antihypertensive medication.
Neldam S; Edwards C
Expert Opin Pharmacother; 2009 Feb; 10(3):345-52. PubMed ID: 19191674
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and long-term safety of a triple combination of 80 mg telmisartan, 5 mg amlodipine and 12.5 mg hydrochlorothiazide in Japanese patients with essential hypertension: a randomized, double-blind study with open-label extension.
Higaki J; Komuro I; Shiki K; Ugai H; Taniguchi A; Ikeda H; Kuroki D; Nishimura S; Ogihara T
Hypertens Res; 2017 Jan; 40(1):51-60. PubMed ID: 27581533
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind comparison of the antihypertensive efficacy and safety of once-daily losartan compared to twice-daily captopril in mild to moderate essential hypertension.
Roca-Cusachs A; Oigman W; Lepe L; Cifkova R; Karpov YA; Harron DW
Acta Cardiol; 1997; 52(6):495-506. PubMed ID: 9542575
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension.
Lee SE; Kim YJ; Lee HY; Yang HM; Park CG; Kim JJ; Kim SK; Rhee MY; Oh BH;
Clin Ther; 2012 Mar; 34(3):552-568, 568.e1-9. PubMed ID: 22381711
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
Lee IT; Hung YJ; Chen JF; Wang CY; Lee WJ; Sheu WH
Clin Ther; 2012 Aug; 34(8):1735-50. PubMed ID: 22784975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]